C-reactive protein levels before reduced-intensity conditioning predict outcome after allogeneic stem cell transplantation

International Journal of Hematology

Volumn 92, Issue 1, 2010, Pages 161-167

  Remberger, Mats ^a   Mattsson, Jonas ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CRP; HSCT; RIC; TRM

Indexed keywords

C REACTIVE PROTEIN;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CHRONIC LEUKEMIA; CONTROLLED STUDY; FEMALE; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; PROGNOSIS; REDUCED INTENSITY CONDITIONING; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFECTION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 77955173114     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0632-7     Document Type: Article

References (26)

1. EA Copelan 2006 Hematopoietic stem-cell transplantation N Engl J Med 354 17 1813 1826 10.1056/NEJMra052638 1:CAS:528:DC%2BD28XjvVarsro%3D 16641398
2. J Mattsson 2008 Recent progress in allogeneic stem cell transplantation Curr Opin Mol Ther 10 4 343 349 18683098
3. U Forslow J Mattsson O Ringden J Klominek M Remberger 2006 Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation Scand J Infect Dis 38 11-12 970 976 10.1080/00365540600786481 17148063
4. H Hebart H Einsele 2004 Specific infectious complications after stem cell transplantation Support Care Cancer 12 2 80 85 10.1007/s00520-003-0511-3 12920624
5. F Baron R Storb 2006 Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders Mol Ther 13 1 26 41 10.1016/j.ymthe.2005.09.011 1:CAS:528:DC%2BD2MXhtlShsrjE 16280257
6. ML Sorror MB Maris R Storb F Baron BM Sandmaier DG Maloney, et al. 2005 Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT Blood 106 8 2912 2919 10.1182/blood-2005-05-2004 1:CAS:528:DC%2BD2MXhtFantbfL 15994282
7. A Gratwohl M Stern R Brand J Apperley H Baldomero T de Witte, et al. 2009 Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis Cancer 115 20 4715 4726 10.1002/cncr.24531 19642176
8. AS Artz A Wickrema S Dinner LA Godley M Kocherginsky O Odenike, et al. 2008 Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation Biol Blood Marrow Transplant 14 11 1209 1216 10.1016/j.bbmt.2008.08.004 18940674
9. Forslow U, Remberger M, Nordlander A, Mattsson J. The clinical importance of bronchoalveolar lavage in allogeneic SCT patients with pneumonia. Bone Marrow Transplant 2009. [Epub ahead of print].
10. M Schaffer A Aldener-Cannava M Remberger O Ringden O Olerup 2003 Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation Tissue Antigens 62 3 243 250 10.1034/j.1399-0039.2003. 00089.x 1:CAS:528:DC%2BD3sXotF2ktbc%3D 12956878
11. M Uzunel M Remberger D Sairafi Z Hassan J Mattsson B Omazic, et al. 2006 Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning Transplantation 82 7 913 919 10.1097/01.tp.0000233865. 20232.51 17038906
12. M Remberger BM Svahn J Mattsson O Ringden 2004 Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation Transplantation 78 1 122 127 1:CAS:528:DC%2BD2cXls1Kisr4%3D 15257050
13. R Storb HJ Deeg J Whitehead F Appelbaum P Beatty W Bensinger, et al. 1986 Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia N Engl J Med 314 12 729 735 10.1056/NEJM198603203141201 1:STN:280: DyaL287ks1OltQ%3D%3D 3513012
14. Kalbfleisch J, Prentice R. The statistical analysis of failure time data. Wiley, New York; 1980.
15. E Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481 10.2307/2281868
16. JJ Nietfeld MC Pasquini BR Logan F Verter MM Horowitz 2008 Lifetime probabilities of hematopoietic stem cell transplantation in the US Biol Blood Marrow Transplant 14 3 316 322 10.1016/j.bbmt.2007.12.493 1:STN:280: DC%2BD1c7hslGktw%3D%3D 18275898
17. R Hehlmann U Berger M Pfirrmann H Heimpel A Hochhaus J Hasford, et al. 2007 Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia Blood 109 11 4686 4692 10.1182/blood-2006-11-055186 1:CAS:528:DC%2BD2sXmt1OgtLg%3D 17317858
18. O Ringden M Labopin G Ehninger D Niederwieser R Olsson N Basara, et al. 2009 Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia J Clin Oncol 27 27 4570 4577 10.1200/JCO.2008.20.9692 19652066
19. F Baron B Storer MB Maris J Storek F Piette M Metcalf, et al. 2006 Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning Biol Blood Marrow Transplant 12 11 1176 1187 10.1016/j.bbmt.2006.07.004 17085311
20. AM Dickinson E Holler 2008 Polymorphisms of cytokine and innate immunity genes and GVHD Best Pract Res Clin Haematol 21 2 149 164 10.1016/j.beha.2008.03. 004 1:CAS:528:DC%2BD1cXmtlyhtrk%3D 18503983
21. NS Majhail CG Brunstein S McAvoy TE DeFor A Al-Hazzouri D Setubal, et al. 2008 Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants Biol Blood Marrow Transplant 14 9 985 992 10.1016/j.bbmt.2008.06.008 1:CAS:528:DC%2BD1cXhtFemurvI 18721761
22. AB Crumley DC McMillan M McKernan JJ Going CJ Shearer RC Stuart 2006 An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer Br J Cancer 94 11 1568 1571 1:CAS:528:DC%2BD28XltVOmtbo%3D 16685271
23. S Fuji SW Kim T Fukuda S Mori S Yamasaki Y Morita-Hoshi, et al. 2008 Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation Biol Blood Marrow Transplant 14 5 510 517 10.1016/j.bbmt.2008.02.008 1:CAS:528:DC%2BD1cXmtFSns7w%3D 18410893
24. R Schots L Kaufman I Van Riet T Ben Othman M De Waele B Van Camp, et al. 2003 Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation Leukemia 17 6 1150 1156 10.1038/sj.leu.2402946 1:CAS:528:DC%2BD3sXjvFKjt7o%3D 12764383
25. M Korppi L Kroger 1993 C-reactive protein in viral and bacterial respiratory infection in children Scand J Infect Dis 25 2 207 213 10.3109/00365549309008486 1:STN:280:DyaK3s3ovFaltw%3D%3D 8511515
26. S Sanders A Barnett I Correa-Velez M Coulthard J Doust 2008 Systematic review of the diagnostic accuracy of C-reactive protein to detect bacterial infection in nonhospitalized infants and children with fever J Pediatr 153 4 570 574 10.1016/j.jpeds.2008.04.023 1:CAS:528:DC%2BD1cXhtFersbrI 18534215